NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹69 Cr | ₹73 Cr | ₹60 Cr | ₹58 Cr | ₹57 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of NEULAND LABORATORIES ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2026 | ₹69 Cr |
| Mar2025 | ₹73 Cr |
| Mar2024 | ₹60 Cr |
| Mar2023 | ₹58 Cr |
| Mar2022 | ₹57 Cr |
How is Deferred Tax Assets / Liabilities of NEULAND LABORATORIES Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹69 Cr | -5.30 | |
| Mar2025 | ₹73 Cr | 20.49 | |
| Mar2024 | ₹60 Cr | 3.67 | |
| Mar2023 | ₹58 Cr | 2.82 | |
| Mar2022 | ₹57 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹25,236.9 Cr | 2% | 4.4% | 34.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹477,408.0 Cr | 1.8% | 5.6% | 16.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹206,906.0 Cr | 0.5% | 13.1% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,521.0 Cr | -2.7% | 5.1% | 42.4% | Stock Analytics | |
| CIPLA | ₹119,032.0 Cr | 2.1% | -0.6% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,420.1 Cr | -4% | -17.5% | -8.6% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 2% |
4.4% |
34.1% |
| SENSEX | 1.2% |
1.2% |
-5.5% |
You may also like the below Video Courses